Last Updated: 04/03/2018
2018 News
- Posted: 04/03/2018
NCI Launches New Resource for Specimens and Data from Cancer Clinical Trials; Cancer Currents Blog Post Featuring Dr. Jeff Abrams and Grace Mishkin - Posted: 03/29/2018
NIH-funded Study Shows Sorafenib Improves Progression-free Survival for Patients with Rare Sarcomas (NCI Press Release) - Posted: 03/20/2018
Schedule of DCTD Staff Presentations at AACR 2018 (April 14-18, 2018; Chicago, IL) - Posted: 03/05/2018
NCI’s Patient-Derived Models Repository Announces New Models Available to the Scientific Community - Posted: 03/05/2018
Can Oxygen “Microbubbles” Make Radiation Therapy More Effective?; Cancer Currents Blog Post Featuring Dr. Eric Bernhard - Posted: 03/05/2018
For Rare Melanoma, Checkpoint Inhibitors May Hold Substantial Promise; Cancer Currents Blog Post Featuring Dr. Elad Sharon - Posted: 02/13/2018
Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations; Cancer Currents Blog Post Featuring Dr. Elise Kohn - Posted: 02/13/2018
Study Identifies Potential Cause of Hearing Loss from Cisplatin; Cancer Currents Blog Post Featuring Dr. Percy Ivy - Posted: 01/24/2018
Nilotinib Can Be Discontinued in Some Patients with Chronic Myelogenous Leukemia; Cancer Currents Blog Post Featuring Dr. Rich Little - Posted: 01/16/2018
New Funding Opportunity Announcement: PAR-18-560: National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)